In the context of leukemia, NF-κB activation leads to the transcription of anti-apoptotic genes, such as BCL-2 and BCL-XL, which help leukemia cells evade apoptosis, induced by chemotherapeutic agents. This evidence concerns the gene BCL2 and leukemia.